Exelixis
EXEL
#1827
Rank
$11.69 B
Marketcap
$43.63
Share price
-1.20%
Change (1 day)
18.40%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: $0.68 Billion USD

According to Exelixis's latest financial reports the company's current earnings are $2.28 Billion USD. In 2024 the company made an earning of $0.68 Billion USD, an increase over its 2023 earnings that were of $0.25 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024$0.68 B164.69%
2023$0.25 B9.89%
2022$0.23 B-20.33%
2021$0.29 B124.82%
2020$0.13 B-67.14%
2019$0.39 B-11.94%
2018$0.45 B185.09%
2017$0.15 B-325.82%
2016-$70.23 Million-58.12%
2015-$0.17 Billion-37.61%
2014-$0.27 Billion9.75%
2013-$0.25 Billion65.96%
2012-$0.15 Billion-291.63%
2011$76.99 M-195.59%
2010-$80.55 Million-42.17%
2009-$0.14 Billion-18.98%
2008-$0.18 Billion-6.99%
2007-$0.19 Billion46.3%
2006-$0.13 Billion33.25%
2005-$94.81 Million-30.92%
2004-$0.14 Billion44.29%
2003-$95.12 Million12.86%
2002-$84.29 Million22.79%
2001-$68.65 Million60.14%
2000-$42.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$32.39 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.24 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$23.09 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$9.32 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-$32.56 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-$29.04 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA